Literature DB >> 3098584

Endocrine changes in the late-follicular and postovulatory intervals as determinants of the in vitro fertilization pregnancy rate.

P W Zarutskie, F B Kuzan, L Dixon, M R Soules.   

Abstract

This investigation examines the hormone pattern in in vitro fertilization (IVF) cycles from the time of human chorionic gonadotropin (hCG) administration through embryo transfer to ascertain whether the absolute levels or secretory patterns of the major reproductive hormones affect the IVF pregnancy rate. Thirty-one women who underwent IVF treatment were enrolled in the study. All patients received clomiphene citrate/human menopausal gonadotropin for ovulation induction. Significant elevations in serum estradiol (E2) levels in the pregnant group were found throughout the cycle interval studied. After hCG administration the serum hCG levels were not different between the groups. Significant elevations in serum progesterone (P) concentrations were found in the pregnant group from the day after laparoscopy through embryo transfer. Embryos obtained from the pregnant group appeared to be different in that the mean number of blastomeres per embryo transferred was significantly greater. Therefore for achievement of an IVF pregnancy the optimal hormone pattern employing combination ovulation induction in the ovulation to transfer interval is a relatively high E2 level in ovulation followed by a high P level at transfer and into the luteal phase. These elevated hormone levels do not depend on the response to exogenous hCG.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3098584     DOI: 10.1016/s0015-0282(16)49949-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme.

Authors:  E M Smith; F W Anthony; S C Gadd; G M Masson
Journal:  BMJ       Date:  1989-06-03

2.  A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization-embryo transfer (IVF-ET) patients.

Authors:  M Dirnfeld; S Goldman; Y Gonen; M Koifman; A Lissak; H Abramovici
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

3.  Super high estradiol response to gonadotropin stimulation in patients undergoing in vitro fertilization.

Authors:  M P Diamond; T Buchholz; S P Boyers; G Lavy; B S Shapiro; A H DeCherney
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-04

4.  Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial.

Authors:  Saghar Salehpour; Maryam Tamimi; Nasrin Saharkhiz
Journal:  Iran J Reprod Med       Date:  2013-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.